| Issue Date | Title | Author(s) |
| 2017-04-01 | Balancing the Optimal and the Feasible: A Practical Guide for Setting Up Patient Registries for the Collection of Real-World Data for Health Care Decision Making Based on Dutch Experiences | de Groot, S; van der Linden, N; Franken, MG; Blommestein, HM; Leeneman, B; van Rooijen, E; Koos van der Hoeven, JJM; Wouters, MW; Westgeest, HM; Uyl-de Groot, CA |
| 2016-01-01 | Costs of non-small cell lung cancer in the Netherlands | van der Linden, N; Bongers, ML; Coupé, VMH; Smit, EF; Groen, HJM; Welling, A; Schramel, FMNH; Uyl-de Groot, CA |
| 2019-03-01 | Determining the Comparative Value of Pharmaceutical Risk-Sharing Policies in Non–Small Cell Lung Cancer Using Real-World Data | Holleman, MS; Uyl-de Groot, CA; Goodall, S; van der Linden, N |
| 2017 | The effectiveness and cost-effectiveness of mandatory folic acid and iodine fortification. A report for the Australian Health Ministers’ Advisory Council | Haywood, P; Goodall, S; Chinchen, E; Haas, M; Manipis, K; Meshcheriakova, O; Saing, S; van der Linden, N |
| 2022-03 | Health care cost of crusted scabies in Aboriginal communities in the Northern Territory, Australia. | Campbell, M; van der Linden, N; Gardner, K; Dickinson, H; Agostino, J; Dowden, M; O'Meara, I; Scolyer, M; Woerle, H; Viney, R; van Gool, K |
| 2018-10-01 | Key considerations in reimbursement decision-making for multiple sclerosis drugs in Australia | Phan, YHL; De Abreu Lourenco, R; Haas, M; van der Linden, N |
| 2019-04-10 | Real-World Cost Effectiveness of Mandatory Folic Acid Fortification of Bread-Making Flour in Australia | Saing, S; Haywood, P; van der Linden, N; Manipis, K; Meshcheriakova, E; Goodall, S |
| 2014-07-16 | Self-referring patients at the emergency department: appropriateness of ED use and motives for self-referral | van der Linden, MC; Lindeboom, R; van der Linden, N; van den Brand, CL; Lam, RC; Lucas, C; de Haan, R; Goslings, JC |
| 2018-03-01 | A systematic review of scabies transmission models and data to evaluate the cost-effectiveness of scabies interventions | van der Linden, N; van Gool, K; Gardner, K; Dickinson, H; Agostino, J; Regan, DG; Dowden, M; Viney, R |
| 2017-09-01 | Treatment Patterns and Differences in Survival of Non-Small Cell Lung Cancer Patients Between Academic and Non-Academic Hospitals in the Netherlands | van der Linden, N; Bongers, ML; Coupé, VMH; Smit, EF; Groen, HJM; Welling, A; Schramel, FMNH; Uyl-de Groot, CA |
| 2016-02-01 | Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands | van der Linden, N; Buter, J; Pescott, CP; Lalisang, RI; de Boer, JP; de Graeff, A; van Herpen, CML; Baatenburg de Jong, RJ; Uyl-de Groot, CA |
| 2014-07-05 | Unscheduled return visits to a Dutch inner-city emergency department | van der Linden, MC; Lindeboom, R; de Haan, R; van der Linden, N; de Deckere, ERJT; Lucas, C; Rhemrev, SJ; Goslings, JC |
| 2019-03-01 | The use of an ‘acclimatisation’ heatwave measure to compare temperature-related demand for emergency services in Australia, Botswana, Netherlands, Pakistan, and USA | van der Linden, N; Longden, T; Richards, JR; Khursheed, M; Goddijn, WMT; van Veelen, MJ; Khan, UR; Christien van der Linden, M |
| 2019-08-01 | Why is There Discordance between the Reimbursement of High-Cost ‘Life-Extending’ Pharmaceuticals and Medical Devices? The Funding of Ventricular Assist Devices in Australia | Saing, S; van der Linden, N; Hayward, C; Goodall, S |
